Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2025-12-25 @ 3:28 AM
NCT ID:
NCT00137605
Eligibility Criteria:
Inclusion Criteria:
* HIV-positive
* Between 18 and 65 years of age
* Have a CD4 cell count below 200 cells/mm3
* Willing to begin/change antiretroviral therapy
* Willing and able to provide informed consent
Exclusion Criteria:
* Pregnant or breastfeeding
* Have had previous pneumococcal vaccination
* Have had occurrence of pneumococcal infection (brain, blood or lung infections) in past 5 years
* Have hypersensitivity to components of either vaccine
* Have acute feverish illness at the time of vaccination
* Have had splenectomy (removal of the spleen)
* Have received treatment with IVIG within the last 6 months
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT00137605
Study Brief:
Protocol Section:
NCT00137605